EV launches the new Group website to mark its transformation journey and the ambition to establish itself as an international solutions provider in the industry.
18.1.2024 11:00:00 EET | Business Wire | Press release
Eigenmann & Veronelli, a leading distributor of specialty chemicals and food ingredients, is launching its new Group website (www.eigver.com) today. The new digital home testifies to EV’s successful transformation over the past years, under the leadership of its Group CEO, Gabriele Bonomi, and to the Company’s ambition to establish itself as an international solutions provider in the industry.
The completely revamped digital environment is the evident expression of EV’s refreshed identity, including an exciting purpose and vision, an ambitious and digitally driven international growth strategy, as well as its solid corporate culture and attractive values.
“We have progressed successfully in many areas since we started our transformation journey. We have strengthened our customer and supplier relationships by becoming a market facilitator and a highly reliable business partner. Our company culture and values, combined with an inspiring purpose and vision provide us with a clear guidance, which is clearly expressed by our identity and new website. It underlines our ambition to be an established international solutions provider in the industry,” said Gabriele Bonomi, Group CEO at EV .
“We firmly believe the new corporate website will be an important showcase for EV, introducing a more contemporary brand experience that distinguishes us and enhances the exciting journey in our Company,” said Federica Urso, Group Corporate Communication Manager at EV . “We want our users to easily find interesting content about EV. We also want to show them who we are and what we do, give them a taste of our Business Groups, and put our people and culture at the center of the storytelling.”
The new website has been designed and developed by the Well done! agency and Lutech Group. It presents a minimalist style and a great wealth of content, which encourages a narrative that is easier to grasp and prompt, with an easy access for visitors via a responsive web design.
|
EIGENMANN & VERONELLI GROUP Founded in 1910, Eigenmann & Veronelli is an international solutions provider of specialty chemicals and food ingredients. Headquartered in Rho (MI), Italy, EV has a direct presence in Italy, Iberia, Turkey and U.A.E. and a commercial reach in more than 40 countries. In 2023, EV generated a consolidated turnover of EUR 345 million with more than 300 employees. The Company is synonymous with effectiveness and efficiency, combining local market knowledge with international chemical innovations, and offering a high-quality and diversified portfolio of specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, and comprehensive regulatory know-how for a wide range of industries. For further information, visit: www.eigver.com Follow us on LinkedIn.
Well done! is an integrated communication agency based in Milan. With over 25 years of experience, it has been the trusted partner for companies seeking strategic support and valuable storytelling for their brand, products, and services.
Lutech Group is a leader in innovation (among the top three in Italy), with 4,700 employees and revenues of about 800 million euros, supporting the transformation and growth of companies and institutions. The group designs, implements and manages end-to-end solutions under the banner of constant improvement involving people and processes, technology, and knowledge. Lutech Group places at the foundation of the Digital Evolution six technological core entities designed to provide a complete and integrated offering, able to meet the manifold needs of digitization: LutechConsulting, LutechSolutions, LutechDigital, LutechCybersecurity, LutechServices and LutechCloud. |
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240118007139/en/
Contact information
Federica Urso
Group PR & Media Relations Manager - @: mediarelations@eigver.it M: (+39) 338 7295116
Miriam Bolzoni
Group PR & Media Relations - @: mediarelations@eigver.it M: (+39) 338 6646747
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release
VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom